Loteprednol Etabonate Suspension/ Drops
Product Images NDC 82260-299

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 82260-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch & Lomb Americas Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Donotuse (Donotuse)

A partial text panel cautioning not to use the product if the neckband imprinted with "Protective Seal" and a yellow indicator is not intact. This likely appears on packaging or labeling of Loteprednol Etabonate ophthalmic suspension to ensure seal integrity.*

FDA Label Image

Chemstructure (Image 01)

Chemical structure of loteprednol etabonate, showing its molecular formula (C24H31ClO7) and molecular weight (466.96). The diagram illustrates the steroid backbone with various functional groups including hydroxyl, ketone, and ester substituents.*

FDA Label Image

Carton (Image 03)

Packaging label for Loteprednol Etabonate Ophthalmic Suspension 0.5%, a sterile ophthalmic suspension in 15 mL volume. The label indicates the product is for ophthalmic use only, prescription use, and includes storage instructions and manufacturer Bausch & Lomb Americas Inc. The label also includes dosage and preservative details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.